Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost

Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which can give false positive results that may result in long term anticoagulation. However, thrombophilia testing is often performed routinely in unselected patients. We analyzed all consecutive thrombophilia testing orders during the months of October and November 2009 at an academic teaching institution. Information was extracted from electronic medical records for the following: indication, timing, comprehensiveness of tests, anticoagulation therapy at the time of testing, and confirmatory repeat testing, if any. Based on the findings of this analysis, we established local guidelines in May 2013 for appropriate thrombophilia testing, primarily to prevent testing during the acute thrombotic event or while the patient is on anticoagulation. We then evaluated ordering practices 22 months after guideline implementation. One hundred seventy-three patients were included in the study. Only 34% (58/173) had appropriate indications (unprovoked venous or arterial thrombosis or pregnancy losses). 51% (61/119) with an index clinical event were tested within one week of the event. Although 46% (79/173) were found to have abnormal results, only 46% of these had the abnormal tests repeated for confirmation with 54% potentially carrying a wrong diagnosis with long term anticoagulation. Twenty-two months after guideline implementation, there was an 84% reduction in ordered tests. Thus, this study revealed that a significant proportion of thrombophilia testing was inappropriately performed. We implemented local guidelines for thrombophilia testing for clinicians, resulting in a reduction in healthcare costs and improved patient care.

[1]  Kenneth R Carson,et al.  The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. , 2013, Blood.

[2]  O. Egeberg Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[3]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[4]  Elaine Gray,et al.  Clinical guidelines for testing for heritable thrombophilia , 2010, British journal of haematology.

[5]  S. Machin,et al.  Pros and cons of thrombophilia testing: cons , 2003, Journal of thrombosis and haemostasis : JTH.

[6]  E. Harris,et al.  The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.

[7]  Matthew D. Krasowski,et al.  Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center , 2015, BMC Medical Informatics and Decision Making.

[8]  M. García-Carrasco,et al.  Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome? , 1997, Clinical and experimental rheumatology.

[9]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[10]  J. Sánchez-Guerrero,et al.  Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. , 1989, The Journal of rheumatology.

[11]  C. Esmon,et al.  Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.

[12]  R. Kistner,et al.  Thrombophilia testing has limited usefulness in clinical decision-making and should be used selectively. , 2015, Journal of vascular surgery. Venous and lymphatic disorders.

[13]  W. Geerts Prevention of venous thromboembolism: a key patient safety priority , 2009, Journal of thrombosis and haemostasis : JTH.

[14]  H. Cohen,et al.  Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome , 2000, British journal of haematology.

[15]  O. Rawley,et al.  Elevated factor VIII levels and risk of venous thrombosis , 2012, British journal of haematology.

[16]  T. Barbui,et al.  Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S , 1994, Thrombosis and Haemostasis.

[17]  Ian Mackie,et al.  Guidelines on the investigation and management of antiphospholipid syndrome , 2012, British journal of haematology.

[18]  Samuel G. Johnson,et al.  Thrombophilia testing patterns amongst patients with acute venous thromboembolism. , 2015, Thrombosis research.

[19]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[20]  P. Reitsma,et al.  Genetic risk factors for venous thrombosis. , 2000, Molecular genetics and metabolism.

[21]  D. Jackson,et al.  A New Inherited Coagulation Disorder Caused by an Abnormal Fibrinogen (‘Fibrinogen Baltimore’) , 1965, Nature.

[22]  J. Griffin,et al.  Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.

[23]  Giuseppe Lippi,et al.  Laboratory investigation of thrombophilia: the good, the bad, and the ugly. , 2009, Seminars in thrombosis and hemostasis.

[24]  S. Das,et al.  Congenital thrombophilia among patients with venous thromboembolism , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[26]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[27]  M. Fisher,et al.  Testing for Inherited Thrombophilias in Arterial Stroke: Can It Cause More Harm Than Good? , 2010, Stroke.